Abstract
The purpose of this study was to investigate erectile dysfunction and associated factors in diabetic patients. Three hundred two patients aged 30–69 and diagnosed with type 2 Diabetes Mellitus (DM) at the internal diseases clinic of a Turkish hospital between January and July 2023 were included in this descriptive, cross-sectional study. The patients’ anthropometric and demographic characteristics, blood lipid and glucose levels, and blood testosterone values were examined. All patients completed the shortened version of the International Index of Erectile Function (IIEF-5) questionnaire. Descriptive statistics and logistic regression analysis were applied. The incidence of erectile dysfunction in the patients with type 2 DM was 54.3%. The patients’ mean age was 48.89 ± 7.87 years. The majority were obese (53.0%) and had comorbidities (66.2%). Duration of diabetes was longer among the patients with erectile dysfunction than in those without (mean duration of DM 84.86 ± 42.49 years and 71.05 ± 25.58 years, respectively, p: 0.001). No diabetes-related complications were observed in 67.2% of the patients, while glycemic control was weak in 44.4% (HbA1c < 7%). Increased body mass index (p = 0.009), lack of physical activity, HbA1C elevation, and low testosterone levels (p < 0.001) emerged as independent indicators of erectile dysfunction (p < 0.05). Erectile dysfunction is very prevalent in diabetic men. The Condition is also increasingly significant as an early clinical indicator for patients with cardiovascular disease. Erectile dysfunction evaluation and management should constitute a standard component in addition to routine laboratory investigation in internal diseases clinics. Clinicians should screen patients with longer durations of diabetes more frequently and refer them for treatment.
Similar content being viewed by others
References
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A.A., Ogurtsova, K., Shaw, J.E., Bright, D., Williams, R., IDF Diabetes Atlas Committee: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 157, 107843 (2019). https://doi.org/10.1016/j.diabres.2019.107843
IDF Diabetes Atlas 9th edition (2019)
Yafi, F.A., Jenkins, L., Albersen, M., Corona, G., Isidori, A.M., Goldfarb, S., Maggi, M., Nelson, C.J., Parish, S., Salonia, A., Tan, R., Mulhall, J.P., Hellstrom, W.J.: Erectile dysfunction. Nat. Rev. Dis. Primers. 2, 16003 (2016). https://doi.org/10.1038/nrdp.2016.3
Ugwumba, F.O., Okafor, C.I., Nnabugwu, I.I., Udeh, E.I., Echetabu, K.N., Okoh, A.D., Okorie, J.C.: Prevalence of, and risk factors for erectile dysfunction in male type 2 diabetic outpatient attendees in Enugu, South East Nigeria. Ann. Afr. Med. 17(4), 215–220 (2018). https://doi.org/10.4103/aam.aam_3_18
Nisahan, B., Kumanan, T., Rajeshkannan, N., Peranantharajah, T., Aravinthan, M.: Erectile dysfunction and associated factors among men with diabetes mellitus from a tertiary diabetic center in Northern Sri Lanka. BMC Res. Notes. 12(1) (2019)
Idung, A., Abasiubong, F., Ukott, I., Udoh, S., Unadike, B.: Prevalence and risk factors of erectile dysfunction in Niger delta region, Nigeria. Afr. Health Sci. 12(2), 160 (2012)
Corona, G., Lee, D.M., Forti, G., O'Connor, D.B., Maggi, M., O'Neill, T.W., Pendleton, N., Bartfai, G., Boonen, S., Casanueva, F.F., Finn, J.D., Giwercman, A., Han, T.S., Huhtaniemi, I.T., Kula, K., Lean, M.E., Punab, M., Silman, A.J., Vanderschueren, D., Wu, F.C., EMAS Study Group. Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). J. Sex. Med. 7(4 Pt 1), 1362–80 (2010). https://doi.org/10.1111/j.1743-6109.2009.01601.x
Lu, C.C., Jiann, B.P., Sun, C.C., Lam, H.C., Chu, C.H., Lee, J.K.: Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes. J. Sex. Med. 6(6), 1719–1728 (2009). https://doi.org/10.1111/j.1743-6109.2009.01219.x
Montorsi, P., Ravagnani, P.M., Galli, S., Rotatori, F., Briganti, A., Salonia, A., Dehò, F., Montorsi, F.: Common grounds for erectile dysfunction and coronary artery disease. Curr. Opin. Urol.. Opin. Urol. 14(6), 361–365 (2004). https://doi.org/10.1097/00042307
De Berardis, G., Pellegrini, F., Franciosi, M., Belfiglio, M., Di Nardo, B., Greenfield, S., Kaplan, S.H., Rossi, M.C., Sacco, M., Tognoni, G., Valentini, M., Nicolucci, A., QuED (Quality of Care and Outcomes in Type 2 Diabetes) Study Group. Longitudinal assessment of quality of life in patients with type 2 diabetes and self-reported erectile dysfunction. Diabetes Care 28(11), 2637–2643 (2005). https://doi.org/10.2337/diacare.28.11.2637. PMID: 16249532
Giuliano, F.A., Leriche, A., Jaudinot, E.O., de Gendre, A.S.: Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology 64, 1196 (2004)
Cleeman, J.I.: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J. Am. Med. Assoc. 285(19), 2486–2497 (2001)
Weldesenbet, A.B., Kebede, S.A., Tusa, B.S.: Prevalence of erectile dysfunction and its associated factors among patients with diabetes in Ethiopia: a systematic review and meta-analysis. J. Int. Med. Res. 49(2), 300060521993318 (2021)
Nieschlag, E., Swerdloff, R., Behre, H.M., Gooren, L.J., Kaufman, J.M., Legros, J.J., Lunenfeld, B., Morley, J.E., Schulman, C., Wang, C., Weidner, W., Wu, F.C.: Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Eur. Urol. 48(1), 1–4 (2005)
Nicolosi, A., Moreira, E.D., Shirai, M., Bin, M.I., Glasser, D.B.: Epidemiology of erectile dysfunction in four countries:Cross-national study of the prevalence and correlates of erectile dysfunction. Urology 61, 201–206 (2003)
Bacon, C.G., Mittleman, M.A., Kawachi, I., Giovannucci, E., Glasser, D.B., Rimm, E.B.: Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann. Int. Med. 139, 161–168 (2003)
Selvin, E., Burnett, A.L., Platz, E.A.: Prevalence and risk factors for erectile dysfunction in the US. Am. J. Med. 120, 151–157 (2007)
Cleveringa, F.G.W., Meulenberg, M.G.G., Gorter, K.J., van den Donk, M., Rutten, G.E.H.M.: The association between erectile dysfunction and cardiovascular risk in men with Type 2 diabetes in primary care: it is a matter of age. J. Diabetes Complicat. 23, 153–159 (2009)
El-Sakka, A.I.: Characteristics of erectile dysfunction in Saudi patients. Int J Impot ResImpot. Res. 16, 13–20 (2004)
El-Sakka, A.I., Tayeb, K.A.: Erectile dysfunction risk factors in noninsulin dependent diabetic Saudi patients. J. Urol. 169, 1043–1047 (2003)
Kouidrat, Y., Pizzol, D., Cosco, T., Thompson, T., Carnaghi, M., Bertoldo, A., Solmi, M., Stubbs, B., Veronese, N.: High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet. Med.. Med. 34(9), 1185–1192 (2017)
Seid, A., Gerensea, H., Tarko, S., Zenebe, Y., Mezemir, R.: Prevalence and determinants of erectile dysfunction among diabetic patients attending in hospitals of central and northwestern zone of Tigray, northern Ethiopia: a cross-sectional study. BMC Endocr. Disord.Endocr. Disord. 17(1), 16 (2017)
Nyalile, K.B., Mushi, E.H.P., Moshi, E., Leyaro, B.J., Msuya, S.E., Mbwambo, O.: Prevalence and factors associated with erectile dysfunction among adult men in Moshi municipal, Tanzania: community-based study. Basic Clin. Androl. 30(1), 1–7 (2020)
De, K.H., De, V.P., Isaacs, S.: Prevalence and characteristics of erectile dysfunction in black and mixed race primary care populations of the Cape Flats and Helderberg Basin area of the Western Cape, South Africa. S. Afr. Fam. Pract. 45(1), 14–20 (2003)
Yang, G., Pan, C., Lu, J.: Prevalence of erectile dysfunction among Chinese men with type 2 diabetes mellitus. Int J Impot ResImpot. Res. 22(5), 310–317 (2010)
Zeleke, M., Hailu, D., Daka, D.: Erectile dysfunction and associated factors among diabetic patients at, Hawassa, Southern, Ethiopia. BMC Endocr. Disord.Endocr. Disord. 21(1), 139 (2021)
Mohamed, A.K., Sonbol, A.: Study of risk factors for erectile dysfunction in patients with type 2 diabetes mellitus: correlation to serum testosterone level. Alex. J. Med. 54, 319–321 (2018)
Shi, M.D., Chao, J.K., Ma, M.C., Chiang, S.K., Chao, I.C.: The connection between type 2 diabetes and erectile dysfunction in Taiwanese aboriginal males. Int J Impot ResImpot. Res. 26, 235–240 (2014)
Tamler, R.: Diabetes, obesity, and erectile dysfunction. Gend. Med.. Med. 6(suppl1), 14–16 (2009)
Ma, R.C., So, W.Y., Yang, X., Yu, L.W., Kong, A.P., Ko, G.T., Chow, C.C., Cockram, C.S., Chan, J.C., Tong, P.C.: Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J. Am. Coll. Cardiol.Cardiol. 51, 2045–2050 (2008)
Esposito, K., Giugliano, F., Di Palo, C., Giugliano, G., Marfella, R., D’Andrea, F., D’Armiento, M., Giugliano, D.: Effect of Iifestyle changes on erecti Ie dysfu nction in obese men: a randomized controlled trial. JAMA 291, 2978–2984 (2004)
Feldman, H.A., Goldstein, I., Hatzichristou, D.G., Krane, R.J., McKinlay, J.B.: Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J. Urol. 151(1), 54–61 (1994)
Giugliano, F., Maiorino, M., Bellastella, G., Gicchino, M., Giugliano, D., Esposito, K.: Determinants of erectile dysfunction in type 2 diabetes. Int J Impot ResImpot. Res. 22(3), 204–209 (2010)
Patel, J.P., Lee, E.H., Mena-Hurtado, C.I., Walker, C.N.: Evaluation and management of erectile dysfunction in the hypertensive patient. Curr. Cardiol. Rep.. Cardiol. Rep. 19(9), 89 (2017)
Nyalile, K.B., Mushi, E.H.P., Moshi, E., Leyaro, B.J., Msuya, S.E., Mbwambo, O.: Prevalence and factors associated with erectile dysfunction among adult men in Moshi municipal, Tanzania: community-based study. Basic Clin. Androl. 30(1), 20 (2020)
Calogero, A.E., Burgio, G., Condorelli, R.A., Cannarella, R., La Vignera, S.: Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. Aging Male 22, 12–19 (2019)
Omar, S.M., Musa, I.R., Idrees, M.B., Abdelbagi, O., Adam, I.: Prevalence and associated factors of erectile dysfunction in men with type 2 diabetes mellitus in eastern Sudan. BMC Endocr. Disord.Endocr. Disord. 22(1), 141 (2022)
Azad, A.K., Setunge, S., Selim, S., Chowdhury, S.H., Rahaman, M.F., Chowdhury, M.A.J., de Courten, B., Ilic, D., Karim, M.N.: Dyslipidaemia as a risk factor for erectile dysfunction in type 2 diabetes mellitus patients. Diabetes Metab. Syndr. Clin. Res. Rev.Metab. Syndr. Clin. Res. Rev. 13(1), 748–753 (2019)
Durmus, N., Toylu, A., Evcim, S., Soner, B.C., Demir, O., Kahraman, E., Demir, T., Irer, B., Gidener, S., Atabey, N., Esen, A.: Time-course changes of nLDL-induced erectile dysfunction. Int J Impot ResImpot. Res. 29(3), 115–119 (2017)
Gholami, S.S., Rogers, R., Chang, J., Ho, H.C., Grazziottin, T., Lin, C.S., Lue, T.F.: The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia. J. Urol. 169(4), 1577–1581 (2003)
Vrentzos, G.E., Paraskevas, K.I., Mikhailidis, D.P.: Dyslipidemia as a risk factor for erectile dysfunction. Curr. Med. Chem.. Med. Chem. 14(16), 1765–1770 (2007)
La Vignera, S., Condorelli, R.A., Vicari, E., Calogero, A.E.: Statins and erectile dysfunction: a critical summary of current evidence. J. Androl.Androl. 33, 552–558 (2012)
Mulligan, T., Frick, M.F., Zuraw, Q.C., Stemhagen, A., McWhirter, C.: Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int. J. Clin. Pract.Clin. Pract. 60(7), 762–769 (2006)
El-Kebbi, I.M., Ziemer, D.C., Cook, C.B., Miller, C.D., Gallina, D.L., Phillips, L.S.: Comorbidity and glycemic control in patients with type 2 diabetes. Arch. Intern. Med. 161(10), 1295–1300 (2001)
Hackett, G., Cole, N., Bhartia, M., Kennedy, D., Raju, J., Wilkinson, P.: Testosterone replacement therapy with long-acting testosterone undeconoate improves sexual function and quality of life parameters vs. placebo in a population of men with type 2 diabetes. J. Sex. Med. 10(6), 1612–1627 (2013)
Isidori, A.M., Giannetta, E., Gianfrilli, D., Greco, E.A., Bonifacio, V., Aversa, A., Isidori, A., Fabbri, A., Lenzi, A.: Effects of testosterone on sexual function in men: results of a meta-analysis. Clin. Endocrinol. (Oxf). Endocrinol. (Oxf) 63(4), 381–394 (2005)
Dean, J.D., Carnegie, C., Rodzvilla, J., Smith, T.: Long-term effects of testim(r) 1% testosterone gel in hypogonadal men. Rev. Urol. 6(Suppl 6), 22–29 (2004)
Acknowledgements
The author is grateful to the Kırklareli Education and Research Hospital for providing access to the Hospital Inpatient Discharge Database. The hospital does not endorse or assume any responsibility for any analyses, interpretations, or conclusions based on the data.
Funding
The author received no financial support for the research, author- ship, and/or publication of this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sayilan, S. Erectile Dysfunction and Associated Factors in Men with Type 2 Diabetes Mellitus. Sex Disabil 42, 189–200 (2024). https://doi.org/10.1007/s11195-023-09831-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11195-023-09831-w